To test these predictions, we examined the effects of conditioned medium (CM) obtained from mGSCs ± TGFBR2 inhibition on the viability and tumor cell-killing capacity of PBMC-derived CD4+ and CD8+ T cells. The gene discussed is CD4; the disease is neoplasm.